Article
Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.
PloS one - 1 Jan 2016
Kumakech Edward, Berggren Vanja, Wabinga Henry, Lillsunde-Larsson Gabriella, Helenius Gisela, Kaliff Malin, Karlsson Mats, Kirimunda Samuel, Musubika Caroline, Andersson Sören
Abstract excerpt
The objective of this study was to determine the prevalence and some predictors for vaccine and non-vaccine types of HPV infections among bivalent HPV vaccinated and non-vaccinated young women in Uganda. This was a comparative cross sectional study 5.5 years after a bivalent HPV 16/18 vaccination (Cervarix®, GlaxoSmithKline, Belgium) pilot project in western Uganda. Cervical swabs were collected between July...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.